Egyptian Drug Authority (EDA) inked a Memorandum of Understanding (MoU) with GlaxoSmithKline (GSK) Egypt to develop the skills of Egyptian pharmacists, EDA stated on March 15th.

EDA said that the move comes within its efforts to achieve institutional excellence, in accordance with the goals of the sustainable development strategy "Egypt's Vision 2030".

The MoU was sigend by EDA’s Chairman's Assistant for Technical Development and Capability Building Affairs Rasha Ziada and GSK Egypt’s General Manager Mohamed El-Dababy.

 

Copyright © 2022 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).